Skip to content

A Study to Compare the effect of Purgation therapy followed by Palashapushpa decoction with jashada Bhasma(zinc oxide) and asanadi decoction with Nishamalaki tablet in the patients of increased sugar levels

A comparative clinical study to evaluate the efficacy of Virechana followed by oral administration of palashapushpa kashaya with jashada bhasma and asanadi kashaya with Nishamalaki vati in the management of madhumeha vis-a-vis type 2 diabetes mellitus - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112771
Enrollment
40
Registered
2026-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Dr VIJAYALAKSHMI BABU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of irrespective gender belonging to the age group 30-60 years Subjects presenting with clinical features of Madhumeha, also including Freshly detected /Recent origin and HbA1C less than 9.5% Subjects presenting with clinical features of Type 2 Diabetes Mellitus. Subjects fit for Virechana Karma.

Exclusion criteria

Exclusion criteria: Subjects presenting with history of Type 1 Diabetes Mellitus. Gestational Diabetes and lactating mothers. Subjects having chronic complications of Diabetes Mellitus. Subjects unfit for Virechana Karma. Any other systemic illness that interferes with the course of intervention.

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is to assess the reduction in fasting blood sugar (FBS) and postprandial blood sugar (PPBS) levels in patients of Madhumeha (Type 2 Diabetes Mellitus) following Virechana therapy with Palashapushpa Kashaya and Jashada Bhasma, and with asanadi Kashaya and Nishamalaki Vati. Reduction in classical symptoms such as polyuria, polydipsia, fatigue, and excessive hunger will be observed. Comparative analysis of overall glycemic control between both groups will be done.Timepoint: 1 year

Secondary

MeasureTime frame
NILTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDR ABDUL KHADER

Sri kalabyraveshwaraswamy Ayurvedic Medical College, Hospital and Research Centre

abukaya2003@gmail.com9845199790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026